beta-Endorphin-induced analgesia is inhibited by synthetic analogs of beta-endorphin.
Competitive antagonism of human beta-endorphin (beta h-EP)-induced analgesia by synthetic beta h-EP analogs with high in vitro opiate receptor binding to in vivo analgesic potency ratio has been demonstrated. A parallel shift of the dose-response curve for analgesia to the right was observed when either beta h-EP or [ Trp27 ] -beta h-EP was coinjected with various doses of [Gln8, Gly31 ]-beta h-EP-Gly-Gly-NH2, [Arg9,19,24,28,29]-beta h-EP, or [ Cys11 ,26, Phe27 , Gly31 ]-beta h-EP. It was estimated that the most potent antagonist, [Gln8, Gly31 ]-beta h-EP-Gly-NH2, is at least 200 times more potent than naloxone.
ACESSO AO ARTIGOhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=345223
- Peptide inhibitor of morphine- and beta-endorphin-induced analgesia.
- beta-endorphin-(1-27) is an antagonist of beta-endorphin analgesia.
- Beta-endorphin-(1-27) is a naturally occurring antagonist to etorphine-induced analgesia.
- Regulation of duodenal bicarbonate secretion during stress by corticotropin-releasing factor and beta-endorphin.
- Absence of opioid stress-induced analgesia in mice lacking beta-endorphin by site-directed mutagenesis.